{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:53:33Z","timestamp":1758272013528},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,12,18]],"date-time":"2003-12-18T00:00:00Z","timestamp":1071705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,12,18]],"date-time":"2003-12-18T00:00:00Z","timestamp":1071705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2004,1,1]]},"DOI":"10.1038\/sj.gt.3302140","type":"journal-article","created":{"date-parts":[[2003,12,18]],"date-time":"2003-12-18T09:02:26Z","timestamp":1071738146000},"page":"25-33","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Functional expression of ATM gene carried by HSV amplicon vector in vitro and in vivo"],"prefix":"10.1038","volume":"11","author":[{"given":"J","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Shackelford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Manuszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"CJ","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,12,18]]},"reference":[{"key":"BF3302140_CR1","first-page":"1","volume":"19","author":"E Boder","year":"1985","unstructured":"Boder E . Ataxia-telangiectasia: an overview. Kroc Found Ser 1985; 19: 1\u201363.","journal-title":"Kroc Found Ser"},{"key":"BF3302140_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF00281059","volume":"75","author":"PJ McKinnon","year":"1987","unstructured":"McKinnon PJ . Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect. Hum Genet 1987; 75: 197\u2013208.","journal-title":"Hum Genet"},{"key":"BF3302140_CR3","volume-title":"Ataxia-telangiectasia","author":"R Sedgwick","year":"1991","unstructured":"Sedgwick R, Boder E . Ataxia-telangiectasia. Elsevier: Amsterdam, 1991."},{"key":"BF3302140_CR4","first-page":"233","volume":"19","author":"HV Vinters","year":"1985","unstructured":"Vinters HV, Gatti RA, Rakic P . Sequence of cellular events in cerebellar ontogeny relevant to expression of neuronal abnormalities in ataxia-telangiectasia. Kroc Found Ser 1985; 19: 233\u2013255.","journal-title":"Kroc Found Ser"},{"key":"BF3302140_CR5","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.7792600","volume":"268","author":"K Savitsky","year":"1995","unstructured":"Savitsky K et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase (see comments). Science 1995; 268: 1749\u20131753.","journal-title":"Science"},{"key":"BF3302140_CR6","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/hmg\/4.11.2025","volume":"4","author":"K Savitsky","year":"1995","unstructured":"Savitsky K et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 1995; 4: 2025\u20132032.","journal-title":"Hum Mol Genet"},{"key":"BF3302140_CR7","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/sj.onc.1201037","volume":"14","author":"D Watters","year":"1997","unstructured":"Watters D et al. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 1997; 14: 1911\u20131921.","journal-title":"Oncogene"},{"key":"BF3302140_CR8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1073\/pnas.97.2.871","volume":"97","author":"C Barlow","year":"2000","unstructured":"Barlow C et al. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc Natl Acad Sci USA 2000; 97: 871\u2013876.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302140_CR9","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/S0960-9822(95)00238-7","volume":"5","author":"SP Jackson","year":"1995","unstructured":"Jackson SP . Cancer predisposition. Ataxia-telangiectasia at the crossroads. Curr Biol 1995; 5: 1210\u20131212.","journal-title":"Curr Biol"},{"key":"BF3302140_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0968-0004(00)89083-0","volume":"20","author":"MF Lavin","year":"1995","unstructured":"Lavin MF et al. Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase. Trends Biochem Sci 1995; 20: 382\u2013383.","journal-title":"Trends Biochem Sci"},{"key":"BF3302140_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0168-9525(00)89112-X","volume":"11","author":"AR Lehmann","year":"1995","unstructured":"Lehmann AR, Carr AM . The ataxia-telangiectasia gene: a link between checkpoint controls, neurodegeneration and cancer. Trends Genet 1995; 11: 375\u2013377.","journal-title":"Trends Genet"},{"key":"BF3302140_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0092-8674(95)90463-8","volume":"82","author":"VA Zakian","year":"1995","unstructured":"Zakian VA . ATM-related genes: what do they tell us about functions of the human gene? Cell 1995; 82: 685\u2013687.","journal-title":"Cell"},{"key":"BF3302140_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/7.10.1555","volume":"7","author":"G Rotman","year":"1998","unstructured":"Rotman G, Shiloh Y . ATM: from gene to function. Hum Mol Genet 1998; 7: 1555\u20131563.","journal-title":"Hum Mol Genet"},{"key":"BF3302140_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/095530098142185","volume":"73","author":"AM Taylor","year":"1998","unstructured":"Taylor AM . What has the cloning of the ATM gene told us about ataxia telangiectasia? Int J Radiat Biol 1998; 73: 365\u2013371.","journal-title":"Int J Radiat Biol"},{"key":"BF3302140_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0065-230X(01)83007-4","volume":"83","author":"Y Shiloh","year":"2001","unstructured":"Shiloh Y, Kastan MB . ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 2001; 83: 209\u2013254.","journal-title":"Adv Cancer Res"},{"key":"BF3302140_CR16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1042\/bst0290661","volume":"29","author":"Y Shiloh","year":"2001","unstructured":"Shiloh Y . ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasis. Biochem Soc Trans 2001; 29: 661\u2013666.","journal-title":"Biochem Soc Trans"},{"key":"BF3302140_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1568-7864(01)00007-6","volume":"1","author":"A Barzilai","year":"2002","unstructured":"Barzilai A, Rotman G, Shiloh Y . ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) 2002; 1: 3\u201325.","journal-title":"DNA Repair (Amst)"},{"key":"BF3302140_CR18","first-page":"739","volume":"2","author":"EA Chiocca","year":"1990","unstructured":"Chiocca EA et al. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol 1990; 2: 739\u2013746.","journal-title":"New Biol"},{"key":"BF3302140_CR19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1126\/science.266.5189.1399","volume":"266","author":"MJ During","year":"1994","unstructured":"During MJ, Naegele JR, O'Malley KL, Geller AI . Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase (see comments). Science 1994; 266: 1399\u20131403.","journal-title":"Science"},{"key":"BF3302140_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s001090000092","volume":"78","author":"JJ Bennett","year":"2000","unstructured":"Bennett JJ et al. Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer. J Mol Med 2000; 78: 166\u2013174.","journal-title":"J Mol Med"},{"key":"BF3302140_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1006\/exnr.2001.7671","volume":"169","author":"A Natsume","year":"2001","unstructured":"Natsume A et al. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp Neurol 2001; 169: 231\u2013238.","journal-title":"Exp Neurol"},{"key":"BF3302140_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1749-6632.2001.tb03643.x","volume":"939","author":"MA Yenari","year":"2001","unstructured":"Yenari MA, Dumas TC, Sapolsky RM, Steinberg GK . Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors. Ann N Y Acad Sci 2001; 939: 340\u2013357.","journal-title":"Ann N Y Acad Sci"},{"key":"BF3302140_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1089\/104303401750195872","volume":"12","author":"PL Poliani","year":"2001","unstructured":"Poliani PL et al. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. Hum Gene Ther 2001; 12: 905\u2013920.","journal-title":"Hum Gene Ther"},{"key":"BF3302140_CR24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.gt.3301205","volume":"7","author":"JM Markert","year":"2000","unstructured":"Markert JM et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Therapy 2000; 7: 867\u2013874.","journal-title":"Gene Therapy"},{"key":"BF3302140_CR25","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.gt.3301184","volume":"7","author":"R Rampling","year":"2000","unstructured":"Rampling R et al. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Therapy 2000; 7: 859\u2013866.","journal-title":"Gene Therapy"},{"key":"BF3302140_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/sj.gt.3301664","volume":"9","author":"V Papanastassiou","year":"2002","unstructured":"Papanastassiou V et al. The potential for efficacy of the modified (ICP 34.5(\u2212)) herpes simplex virus HSV1716 following intratumoral injection into human malignant glioma: a proof of principle study. Gene Therapy 2002; 9: 398\u2013406.","journal-title":"Gene Therapy"},{"key":"BF3302140_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0092-8674(82)90035-6","volume":"30","author":"RR Spaete","year":"1982","unstructured":"Spaete RR, Frenkel N . The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 1982; 30: 295\u2013304.","journal-title":"Cell"},{"key":"BF3302140_CR28","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1126\/science.2843986","volume":"241","author":"AI Geller","year":"1988","unstructured":"Geller AI, Breakefield XO . A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science 1988; 241: 1667\u20131669.","journal-title":"Science"},{"key":"BF3302140_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1073\/pnas.87.3.1149","volume":"87","author":"AI Geller","year":"1990","unstructured":"Geller AI, Freese A . Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase. Proc Natl Acad Sci USA 1990; 87: 1149\u20131153.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302140_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0042-6822(85)90351-4","volume":"142","author":"AD Kwong","year":"1985","unstructured":"Kwong AD, Frenkel N . The herpes simplex virus amplicon. IV. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomes. Virology 1985; 142: 421\u2013425.","journal-title":"Virology"},{"key":"BF3302140_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0002-9610(98)00231-1","volume":"176","author":"JF Carew","year":"1998","unstructured":"Carew JF et al. Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector. Am J Surg 1998; 176: 404\u2013408.","journal-title":"Am J Surg"},{"key":"BF3302140_CR32","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0306-4522(98)00093-1","volume":"86","author":"MA Levatte","year":"1998","unstructured":"Levatte MA, Cassam AK, Dekaban GA, Weaver LC . Analysis of a multi-mutant herpes simplex virus type 1 for gene transfer into sympathetic preganglionic neurons and a comparison to adenovirus vectors. Neuroscience 1998; 86: 1321\u20131336.","journal-title":"Neuroscience"},{"key":"BF3302140_CR33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/sj.gt.3300523","volume":"4","author":"S Wang","year":"1997","unstructured":"Wang S et al. A novel herpes virus amplicon system for in vivo gene delivery. Gene Therapy 1997; 4: 1132\u20131141.","journal-title":"Gene Therapy"},{"key":"BF3302140_CR34","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1128\/jvi.70.12.8422-8430.1996","volume":"70","author":"S Wang","year":"1996","unstructured":"Wang S, Vos J . A hybrid herpes virus infectious vector based on Epstein\u2013Barr virus and Herpes Simplex Virus type 1 for gene transfer into human cells in vitro and in vivo. J Virol 1996; 70: 8422\u20138430.","journal-title":"J Virol"},{"key":"BF3302140_CR35","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1073\/pnas.96.7.4078","volume":"96","author":"M Yamada","year":"1999","unstructured":"Yamada M et al. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc Natl Acad Sci USA 1999; 96: 4078\u20134083.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302140_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/mthe.2000.0058","volume":"1","author":"CA Strathdee","year":"2000","unstructured":"Strathdee CA, McLeod MR . A modular set of helper-dependent herpes simplex virus expression vectors. Mol Ther 2000; 1: 479\u2013485.","journal-title":"Mol Ther"},{"key":"BF3302140_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0166-2236(99)01539-8","volume":"23","author":"M Simonato","year":"2000","unstructured":"Simonato M, Manservigi R, Marconi P, Glorioso J . Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors. Trends Neurosci 2000; 23: 183\u2013190.","journal-title":"Trends Neurosci"},{"key":"BF3302140_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/10430340252837251","volume":"13","author":"M Agudo","year":"2002","unstructured":"Agudo M et al. Highly efficient and specific gene transfer to Purkinje cells in vivo using a herpes simplex virus I amplicon. Hum Gene Ther 2002; 13: 665\u2013674.","journal-title":"Hum Gene Ther"},{"key":"BF3302140_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/geno.1996.0201","volume":"33","author":"T Uziel","year":"1996","unstructured":"Uziel T et al. Genomic organization of the ATM gene. Genomics 1996; 33: 317\u2013320.","journal-title":"Genomics"},{"key":"BF3302140_CR40","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1073\/pnas.94.15.8021","volume":"94","author":"N Zhang","year":"1997","unstructured":"Zhang N et al. Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. Proc Natl Acad Sci USA 1997; 94: 8021\u20138026.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302140_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.onc.1201319","volume":"15","author":"Y Ziv","year":"1997","unstructured":"Ziv Y et al. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 1997; 15: 159\u2013167.","journal-title":"Oncogene"},{"key":"BF3302140_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/bbrc.1998.8137","volume":"245","author":"SP Scott","year":"1998","unstructured":"Scott SP et al. Cloning and expression of the ataxia-telangiectasia gene in baculovirus. Biochem Biophys Res Commun 1998; 245: 144\u2013148.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302140_CR43","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1073\/pnas.90.8.3655","volume":"90","author":"DY Ho","year":"1993","unstructured":"Ho DY, Mocarski ES, Sapolsky RM . Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci USA 1993; 90: 3655\u20133659.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302140_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s002620050530","volume":"47","author":"M D'Angelica","year":"1999","unstructured":"D'Angelica M et al. In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors. Cancer Immunol Immunother 1999; 47: 265\u2013271.","journal-title":"Cancer Immunol Immunother"},{"key":"BF3302140_CR45","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/sj.gt.3300882","volume":"6","author":"P Marconi","year":"1999","unstructured":"Marconi P et al. Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo. Gene Therapy 1999; 6: 904\u2013912.","journal-title":"Gene Therapy"},{"key":"BF3302140_CR46","first-page":"225","volume":"19","author":"RA Gatti","year":"1985","unstructured":"Gatti RA, Vinters HV . Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. Kroc Found Ser 1985; 19: 225\u2013232.","journal-title":"Kroc Found Ser"},{"key":"BF3302140_CR47","first-page":"2707","volume":"13","author":"ND Lakin","year":"1996","unstructured":"Lakin ND et al. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 1996; 13: 2707\u20132716.","journal-title":"Oncogene"},{"key":"BF3302140_CR48","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0306-4522(98)00117-1","volume":"86","author":"HD Soares","year":"1998","unstructured":"Soares HD, Morgan JI, McKinnon PJ . Atm expression patterns suggest a contribution from the peripheral nervous system to the phenotype of ataxia-telangiectasia. Neuroscience 1998; 86: 1045\u20131054.","journal-title":"Neuroscience"},{"key":"BF3302140_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0304-3940(98)00576-X","volume":"252","author":"A Oka","year":"1998","unstructured":"Oka A, Takashima S . Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development. Neurosci Lett 1998; 252: 195\u2013198.","journal-title":"Neurosci Lett"},{"key":"BF3302140_CR50","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1128\/jvi.66.5.2952-2965.1992","volume":"66","author":"PA Johnson","year":"1992","unstructured":"Johnson PA et al. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol 1992; 66: 2952\u20132965.","journal-title":"J Virol"},{"key":"BF3302140_CR51","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1097\/00001756-199512150-00002","volume":"6","author":"BA Sabel","year":"1995","unstructured":"Sabel BA, Vick A, Holt V . Neurotoxic reactions of CNS following gene transfer with defective herpes simplex virus (HSV-1) vector. NeuroReport 1995; 6: 2447\u20132449.","journal-title":"NeuroReport"},{"key":"BF3302140_CR52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02907473","volume":"4","author":"JC Glorioso","year":"1995","unstructured":"Glorioso JC et al. HSV as a gene transfer vector for the nervous system. Mol Biotechnol 1995; 4: 87\u201399.","journal-title":"Mol Biotechnol"},{"key":"BF3302140_CR53","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1128\/jvi.70.9.6358-6369.1996","volume":"70","author":"N Wu","year":"1996","unstructured":"Wu N, Watkins SC, Schaffer PA, DeLuca NA . Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol 1996; 70: 6358\u20136369.","journal-title":"J Virol"},{"key":"BF3302140_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nm0397-357","volume":"3","author":"DJ Fink","year":"1997","unstructured":"Fink DJ, Glorioso JC . Engineering herpes simplex virus vectors for gene transfer to neurons. Nat Med 1997; 3: 357\u2013359.","journal-title":"Nat Med"},{"key":"BF3302140_CR55","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1128\/jvi.71.6.4614-4625.1997","volume":"71","author":"LA Samaniego","year":"1997","unstructured":"Samaniego LA, Wu N, DeLuca NA . The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol 1997; 71: 4614\u20134625.","journal-title":"J Virol"},{"key":"BF3302140_CR56","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/sj.gt.3300766","volume":"5","author":"DM Krisky","year":"1998","unstructured":"Krisky DM et al. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Therapy 1998; 5: 1593\u20131603.","journal-title":"Gene Therapy"},{"key":"BF3302140_CR57","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1128\/JVI.75.9.4343-4356.2001","volume":"75","author":"CE Lilley","year":"2001","unstructured":"Lilley CE et al. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J Virol 2001; 75: 4343\u20134356.","journal-title":"J Virol"},{"key":"BF3302140_CR58","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0958-1669(02)00359-2","volume":"13","author":"EA Burton","year":"2002","unstructured":"Burton EA, Bai Q, Goins WF, Glorioso JC . Replication-defective genomic herpes simplex vectors: design and production. Curr Opin Biotechnol 2002; 13: 424\u2013428.","journal-title":"Curr Opin Biotechnol"},{"key":"BF3302140_CR59","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1128\/jvi.70.10.7190-7197.1996","volume":"70","author":"C Fraefel","year":"1996","unstructured":"Fraefel C et al. Helper virus-free transfer of Herpes simplex virus type 1 plasmid vectors into neural cells. J Virol 1996; 70: 7190\u20137197.","journal-title":"J Virol"},{"key":"BF3302140_CR60","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1128\/JVI.72.9.7137-7143.1998","volume":"72","author":"TA Stavropoulos","year":"1998","unstructured":"Stavropoulos TA, Strathdee CA . An enhanced packaging system for helper-dependent herpes simplex virus vectors. J Virol 1998; 72: 7137\u20137143.","journal-title":"J Virol"},{"key":"BF3302140_CR61","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1006\/mthe.2001.0294","volume":"3","author":"Y Saeki","year":"2001","unstructured":"Saeki Y et al. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol Ther 2001; 3: 591\u2013601.","journal-title":"Mol Ther"},{"key":"BF3302140_CR62","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/104303401750061221","volume":"12","author":"C Logvinoff","year":"2001","unstructured":"Logvinoff C, Epstein AL . A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus. Hum Gene Ther 2001; 12: 161\u2013167.","journal-title":"Hum Gene Ther"},{"key":"BF3302140_CR63","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1525-0016(02)00036-9","volume":"7","author":"JA Olschowka","year":"2003","unstructured":"Olschowka JA et al. Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol Ther 2003; 7: 218\u2013227.","journal-title":"Mol Ther"},{"key":"BF3302140_CR64","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0042-6822(92)90062-T","volume":"186","author":"IL Smith","year":"1992","unstructured":"Smith IL, Hardwicke MA, Sandri-Goldin RM . Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 1992; 186: 74\u201386.","journal-title":"Virology"},{"key":"BF3302140_CR65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/jvi.63.1.18-27.1989","volume":"63","author":"AM McCarthy","year":"1989","unstructured":"McCarthy AM, McMahan L, Schaffer PA . Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol 1989; 63: 18\u201327.","journal-title":"J Virol"},{"key":"BF3302140_CR66","doi-asserted-by":"publisher","first-page":"21951","DOI":"10.1074\/jbc.M011303200","volume":"276","author":"RE Shackelford","year":"2001","unstructured":"Shackelford RE et al. The ataxia telangiectasia gene product is required for oxidative stress-induced G1 and G2 checkpoint function in human fibroblasts. J Biol Chem 2001; 276: 21951\u201321959.","journal-title":"J Biol Chem"},{"key":"BF3302140_CR67","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C . The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego, CA, 1986."}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302140","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:11:39Z","timestamp":1648606299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,18]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1,1]]}},"alternative-id":["BF3302140"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302140","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,18]]},"assertion":[{"value":"10 January 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}